A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes

被引:22
作者
Schranz, DB
Bekris, L
Landin-Olsson, M
Törn, C
Niläng, A
Toll, S
Grönlund, H
Toivola, B
Lernmark, A
机构
[1] Univ Washington, Dept Med, Robert H Williams Lab, Seattle, WA 98195 USA
[2] Univ Lund Hosp, Dept Med, S-22185 Lund, Sweden
[3] Pharmacia Diagnost AB, S-75182 Uppsala, Sweden
[4] Univ Washington, Lab Med, Seattle, WA 98195 USA
关键词
autoimmunity; radio-antigen binding assay; microSepharose; islet cell autoantibodies; ROC curve; type; 1; diabetes;
D O I
10.1016/S0022-1759(98)00025-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
GAD65Ab and ICA512Ab are strongly associated with insulin-dependent (Type 1) diabetes mellitus. A novel, simple radio-antigen binding assay with microSepharose conjugated with monoclonal antibodies specific for human immunoglobulin light chains was developed to provide diagnostic sensitivity and specificity of GAD65Ab and ICA512Ab for Type 1 diabetes. The Receiver Operating Characteristic (ROC) curve was used to determine the upper level of Normal in 583 new onset Type 1 diabetic patients and in 829 matched controls. The sensitivity of GAD65Ab and ICA512Ab was 66% (384/583) and 41% (211/520), respectively, and the diagnostic specificity was 96% for both autoantibodies. Levels, but not frequency, of GAD65Ab were higher among female Type 1 diabetes patients, whereas ICA512Ab levels did not differ between males and females. Positivity for GAD65Ab, ICA512Ab or both showed a sensitivity of 74% and a specificity of 92% for Type 1 diabetes. This simple, one-step centrifugation, high-capacity radio-antigen binding assay has a high precision and reproducibility to accurately detect both GAD65Ab and ICA512Ab, This assay should also prove useful in other autoantibody assays against conformation-sensitive autoantigens. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:87 / 97
页数:11
相关论文
共 50 条
  • [41] GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response
    Cheramy, Mikael
    Skoglund, Camilla
    Johansson, Ingela
    Ludvigsson, Johnny
    Hampe, Christiane S.
    Casas, Rosaura
    CLINICAL IMMUNOLOGY, 2010, 137 (01) : 31 - 40
  • [42] Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: Improvement with high-dose intravenous immunoglobulin therapy
    Lopez-Sublet, M.
    Bihan, H.
    Reach, G.
    Dupont, S.
    Didelot, A.
    Mourad, J. -J.
    Krivitzky, A.
    Dhote, R.
    DIABETES & METABOLISM, 2012, 38 (03) : 273 - 275
  • [43] Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585)
    Teoh, KL
    Fida, S
    Rowley, MJ
    Mackay, IR
    AUTOIMMUNITY, 1998, 28 (04) : 259 - 266
  • [44] The association between the PTPN22 1858C> T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies
    Maziarz, M.
    Janer, M.
    Roach, J. C.
    Hagopian, W.
    Palmer, J. P.
    Deutsch, K.
    Sanjeevi, C. B.
    Kockum, I.
    Breslow, N.
    Lernmark, A.
    GENES AND IMMUNITY, 2010, 11 (05) : 406 - 415
  • [45] IAA, GAD65 AND IA2 Antibodies In Type 1 Diabetes Mellitus Children And Adolescents
    Khan, Yasir Naqi
    Ashfaq, Muhammad
    Bader-u-Nisa
    Yasir, Mehrunnisa
    Waseem, Hira
    Kanpurwala, Muhammad Adnan
    ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2021, 26 (03): : 114 - 120
  • [46] Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset
    Dotta, F
    Falorni, A
    Tiberti, C
    Dionisi, S
    Anastasi, E
    Torresi, P
    Lernmark, A
    Di Mario, U
    JOURNAL OF AUTOIMMUNITY, 1997, 10 (06) : 585 - 588
  • [47] Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology
    Plesner, A
    Worsaae, A
    Dyrberg, T
    Gotfredsen, C
    Michelsen, BK
    Petersen, JS
    JOURNAL OF AUTOIMMUNITY, 1998, 11 (04) : 335 - 341
  • [48] GAD65 and insulin B chain peptide (9-23) are not primary autoantigens in the type 1 diabetes syndrome of the BB rat
    Bieg, S
    Hanlon, C
    Hampe, CS
    Benjamin, D
    Mahoney, CP
    AUTOIMMUNITY, 1999, 31 (01) : 15 - 24
  • [49] HLA-DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
    Chuzho, Neihenuo
    Mishra, Neetu
    Tandon, Nikhil
    Kanga, Uma
    Mishra, Gunja
    Sharma, Akanksha
    Mehra, Narinder K. K.
    Kumar, Neeraj
    JOURNAL OF DIABETES, 2023, : 607 - 621
  • [50] Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels
    Bekris, L. M.
    Shephard, C.
    Janer, M.
    Graham, J.
    McNeney, B.
    Shin, J.
    Zarghami, M.
    Griffith, W.
    Farin, F.
    Kavanagh, T. J.
    Lernmark, A.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (04) : 221 - 228